CFLAR and cancer: Taken together, these studies suggest that hnRNPK may up-regulate the c-FLIP protein level in cancer cells through two different mechanisms and at two different subcellular locations to antagonize the apoptotic effect of TRAIL, which would make this protein an interesting target for the combinatorial therapy with TRAIL.